Verrica Pharmaceuticals (VRCA) Debt to Equity (2021 - 2025)
Historic Debt to Equity for Verrica Pharmaceuticals (VRCA) over the last 4 years, with Q3 2025 value amounting to -$0.73.
- Verrica Pharmaceuticals' Debt to Equity changed N/A to -$0.73 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.73, marking a year-over-year change of. This contributed to the annual value of -$1.31 for FY2024, which is N/A changed from last year.
- As of Q3 2025, Verrica Pharmaceuticals' Debt to Equity stood at -$0.73.
- In the past 5 years, Verrica Pharmaceuticals' Debt to Equity ranged from a high of $2.59 in Q2 2022 and a low of -$1.31 during Q4 2024
- In the last 4 years, Verrica Pharmaceuticals' Debt to Equity had a median value of $0.72 in 2021 and averaged $0.45.
- Data for Verrica Pharmaceuticals' Debt to Equity shows a peak YoY increase of 22935.93% (in 2022) and a maximum YoY decrease of 15112.67% (in 2022) over the last 5 years.
- Verrica Pharmaceuticals' Debt to Equity (Quarter) stood at $1.28 in 2021, then skyrocketed by 102.5% to $2.59 in 2022, then tumbled by 150.67% to -$1.31 in 2024, then skyrocketed by 44.28% to -$0.73 in 2025.
- Its last three reported values are -$0.73 in Q3 2025, -$0.72 for Q2 2025, and -$0.69 during Q1 2025.